Amedisys, Inc. (ADY.F)
- Previous Close
83.50 - Open
84.00 - Bid 84.00 x 10000
- Ask 86.50 x 10000
- Day's Range
83.50 - 84.00 - 52 Week Range
66.00 - 88.00 - Volume
114 - Avg. Volume
7 - Market Cap (intraday)
2.78B - Beta (5Y Monthly) 0.86
- PE Ratio (TTM)
-- - EPS (TTM)
-0.28 - Earnings Date May 1, 2024 - May 6, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
230.13
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
www.amedisys.com19,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ADY.F
Performance Overview: ADY.F
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ADY.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ADY.F
Valuation Measures
Market Cap
2.78B
Enterprise Value
3.12B
Trailing P/E
--
Forward P/E
19.68
PEG Ratio (5yr expected)
1.37
Price/Sales (ttm)
1.30
Price/Book (mrq)
2.73
Enterprise Value/Revenue
1.39
Enterprise Value/EBITDA
24.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-0.44%
Return on Assets (ttm)
5.98%
Return on Equity (ttm)
-0.98%
Revenue (ttm)
2.24B
Net Income Avi to Common (ttm)
-9.75M
Diluted EPS (ttm)
-0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
126.45M
Total Debt/Equity (mrq)
43.51%
Levered Free Cash Flow (ttm)
258.61M